ACR 2019

American College of Rheumatology/Association of Rheumatology Professionals Annual Meeting
8–13 November 2019, Atlanta, Georgia, USA
CONTENTS
Online First
Late-Breaking Abstracts
Lowest Risk of Infection after Therapy with an IL-12/IL-23 Blocker

Calcium Pyrophosphate Deposition Disease: An Independent Risk Factor for Cardiovascular Complications
Proteome Abnormalities Improve Prediction of RA Development
RA Patients in Remission Benefit from Continued Therapy with Conventional DMARDs

Selective IL-23 Blocker Shows Remarkable Efficacy in Patients with Psoriatic Arthritis
What is Hot in Systemic Lupus Erythematosus
Anifrolumab Succeeds in Second Phase 3 Trial in SLE

Depression Closely Related to Fatigue in SLE Patients
Osteoarthritis – State-of-the-Art

Hand OA: Low-dose Corticosteroids Improve Symptoms
Opioids: No Quality of Life Benefits for OA Patients
Reproductive Issues in Rheumatic Disease
Few Serious Infections in Offspring with Exposure to Non-TNFI Biologics or Tofacitinib
Prevention of Congenital Heart Block May Be Possible with Hydroxychloroquine

TNFi for RA During Pregnancy-to Stop or Not to Stop?
Vasculitis – Novel Treatment Modalities
Rituximab Maintenance Superior to Azathioprine in ANCA-associated Vasculitis
Prolonged Remission after Stop of Tocilizumab for Patients with Giant Cell Arteritis
Best of the Posters
